Consumer Confidential: Pfizer's 'business as normal' vow: More price increases?

"Business as normal."

With those three words, the chief executive of pharmaceutical giant Pfizer declared last week that his company, and by extension the drug industry, is dropping any pretense of being open to price cuts and will continue gouging sick people as much as they can.

After reporting a 45 percent increase in quarterly profit - 45 percent! - Ian Read was asked about possible pushback from the Trump administration if he announced price increases in January after earlier saying the company would reconsider its strategy of regular increases.

"I expect our approach by the end of year will